Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 1,234Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6Rupafin

PharmaCompass

01

Brand Name : Rupafin

Rupatadine

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Rupafin

arrow
Medlab Asia & Asia Health
Not Confirmed

Rupatadine

Main Therapeutic Indication : Immunology

Currency : USD

2020 Revenue in Millions : 73

2019 Revenue in Millions : 52

Growth (%) : 39

blank

02

Brand Name : Rupafin

Rupatadine

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Rupafin

arrow
Medlab Asia & Asia Health
Not Confirmed

Rupatadine

Main Therapeutic Indication : Immunology

Currency : USD

2021 Revenue in Millions : 75

2020 Revenue in Millions : 72

Growth (%) : 13

blank

03

Brand Name : Rupafin

Rupatadine

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Rupafin

arrow
Medlab Asia & Asia Health
Not Confirmed

Rupatadine

Main Therapeutic Indication : Immunology

Currency : USD

2022 Revenue in Millions : 74

2021 Revenue in Millions : 74

Growth (%) : 0

blank

04

Brand Name : Rupafin

Rupatadine

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Rupafin

arrow
Medlab Asia & Asia Health
Not Confirmed

Rupatadine

Main Therapeutic Indication : Immunology

Currency : USD

2023 Revenue in Millions : 65

2022 Revenue in Millions : 74

Growth (%) : -2

blank

05

Brand Name : Rupafin

Rupatadine

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Rupafin

arrow
Medlab Asia & Asia Health
Not Confirmed

Rupatadine

Main Therapeutic Indication : Anti-Allergic

Currency : USD

2018 Revenue in Millions : 9

2017 Revenue in Millions : 0

Growth (%) : NA

blank

06

Brand Name : Rupafin

Rupatadine

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Rupafin

arrow
Medlab Asia & Asia Health
Not Confirmed

Rupatadine

Main Therapeutic Indication : Immunology

Currency : USD

2019 Revenue in Millions : 60

2018 Revenue in Millions : 9

Growth (%) : 550

blank